Keyserling H - Search Results

1

A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics.

Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Johnson C, Madore D, Hogerman D. Steinhoff MC, et al. Among authors: keyserling h. Pediatr Infect Dis J. 1994 May;13(5):368-72. doi: 10.1097/00006454-199405000-00007. Pediatr Infect Dis J. 1994. PMID: 8072818 Clinical Trial.

2

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D. O'Brien KL, et al. Among authors: keyserling h. Pediatr Infect Dis J. 1996 May;15(5):425-30. doi: 10.1097/00006454-199605000-00009. Pediatr Infect Dis J. 1996. PMID: 8724065 Clinical Trial.

3

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR. Rennels MB, et al. Among authors: keyserling hl. Pediatr Infect Dis J. 2001 Feb;20(2):153-9. doi: 10.1097/00006454-200102000-00007. Pediatr Infect Dis J. 2001. PMID: 11224833 Clinical Trial.

4

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines.

Daum RS, Hogerman D, Rennels MB, Bewley K, Malinoski F, Rothstein E, Reisinger K, Block S, Keyserling H, Steinhoff M. Daum RS, et al. Among authors: keyserling h. J Infect Dis. 1997 Aug;176(2):445-55. doi: 10.1086/514063. J Infect Dis. 1997. PMID: 9237711 Clinical Trial.

5

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A. Rennels MB, et al. Among authors: keyserling hl. Pediatrics. 1998 Apr;101(4 Pt 1):604-11. doi: 10.1542/peds.101.4.604. Pediatrics. 1998. PMID: 9521941 Clinical Trial.

6

Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.

Paradiso PR, Hogerman DA, Madore DV, Keyserling H, King J, Reisinger KS, Blatter MM, Rothstein E, Bernstein HH, Hackell J. Paradiso PR, et al. Among authors: keyserling h. Pediatrics. 1993 Dec;92(6):827-32. Pediatrics. 1993. PMID: 8233745 Clinical Trial.

7

Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

Halasa NB, Gerber MA, Berry AA, Anderson EL, Winokur P, Keyserling H, Eckard AR, Hill H, Wolff MC, McNeal MM, Edwards KM, Bernstein DI. Halasa NB, et al. Among authors: keyserling h. J Pediatric Infect Dis Soc. 2015 Sep;4(3):214-24. doi: 10.1093/jpids/piu061. Epub 2014 Jun 27. J Pediatric Infect Dis Soc. 2015. PMID: 26334249 Free PMC article. Clinical Trial.

8

Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.

Callahan ST, Wolff M, Hill HR, Edwards KM; NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. Callahan ST, et al. J Infect Dis. 2014 Oct 15;210(8):1270-4. doi: 10.1093/infdis/jiu245. Epub 2014 May 1. J Infect Dis. 2014. PMID: 24795475 Free PMC article. Clinical Trial.

9

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.

Frey SE, Wald A, Edupuganti S, Jackson LA, Stapleton JT, El Sahly H, El-Kamary SS, Edwards K, Keyserling H, Winokur P, Keitel W, Hill H, Goll JB, Anderson EL, Graham IL, Johnston C, Mulligan M, Rouphael N, Atmar R, Patel S, Chen W, Kotloff K, Creech CB, Chaplin P, Belshe RB. Frey SE, et al. Among authors: keyserling h. Vaccine. 2015 Sep 22;33(39):5225-34. doi: 10.1016/j.vaccine.2015.06.075. Epub 2015 Jul 2. Vaccine. 2015. PMID: 26143613 Free PMC article. Clinical Trial.

10

Antigen excretion in the urine after pneumococcal vaccination.

Kelley R, Keyserling H. Kelley R, et al. Among authors: keyserling h. Pediatr Infect Dis J. 1997 Jul;16(7):720. doi: 10.1097/00006454-199707000-00020. Pediatr Infect Dis J. 1997. PMID: 9239782 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page